Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 166 - 176 of 176 items.
Jamp-Glucose 50 and Jamp-Glucose 75 – Risk of False Negative Oral Glucose Challenge or Tolerance Test Results
AlertHealth professional risk communication | 2018-06-07
New safety information for women using dolutegravir, a medication used to treat HIV infection
AlertInformation update | 2018-06-07
Barbed Sutures and the Potential Risk of Small Bowel Obstruction
AlertHealth professional risk communication | 2018-05-31
Several GlaxoSmithKline Inc. vaccines: Potential Risk of Underdosing
AlertHealth professional risk communication | 2018-05-01
Percutaneous Radiofrequency Ablation Catheter and the Potential Risk of Atrioesophageal Fistula
AlertHealth professional risk communication | 2018-04-16
Women taking birth control pills reminded to return any packages for replacement if the pills are missing or look unusual
AlertPublic advisory | 2018-04-16
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
AlertHealth professional risk communication | 2018-03-16
Chipped pills in additional packages of Alysena 21 and 28 birth control pills
AlertPublic advisory | 2018-03-08
Shortage of Erwinase for Injection and Replacement with UK Labelled Stock
AlertHealth professional risk communication | 2018-02-27
TECENTRIQ (atezolizumab) - Risk of Myocarditis
AlertHealth professional risk communication | 2018-02-14
OFEV (nintedanib) - Risk of Drug-Induced Liver Injury and the Need for Regular Monitoring of Liver Function
AlertHealth professional risk communication | 2018-01-11